zidovudine triphosphate has been researched along with foscarnet in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 8 (53.33) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brideau, RJ; Cudahy, MM; Homa, FL; Hopkins, TA; Knechtel, ML; Oien, NL; Pitts, TW; Poorman, RA; Schnute, ME; Wathen, MW; Wieber, JL | 1 |
Dornadula, G; Grobler, JA; Hazuda, DJ; Miller, MD; Rice, MR; Simcoe, AL | 1 |
Anderson, DJ; Brideau, RJ; Ciske, FL; Collier, SA; Cudahy, MM; Eggen, M; Genin, MJ; Hopkins, TA; Judge, TM; Kim, EJ; Knechtel, ML; Nair, SK; Nieman, JA; Oien, NL; Schnute, ME; Scott, A; Tanis, SP; Vaillancourt, VA; Wathen, MW; Wieber, JL | 1 |
Brideau, RJ; DiPaolo, BA; Hageman, MJ; Hopkins, TA; Knechtel, ML; Larsen, SD; Manninen, PR; Oien, NL; Rohrer, DC; Rush, BD; Schwende, FJ; Stefanski, KJ; Wathen, MW; Wieber, JL; Wilkinson, KF; Zamora, KM; Zhang, Z | 1 |
Brideau, RJ; Collier, SA; Cudahy, MM; Hopkins, TA; Knechtel, ML; Oien, NL; Sackett, RS; Schnute, ME; Scott, A; Stephan, ML; Wathen, MW; Wieber, JL | 1 |
Hopkins, TA; Knechtel, ML; Moon, MW; Oien, NL; Parker, TT; Perrault, WR; Stephanski, KJ; Strohbach, JW; Tanis, SP; Thaisrivongs, S; Wathen, MW; Wieber, JL | 1 |
Chen, K; Heasley, SE; Hopkins, TA; Knechtel, ML; Nair, SK; Nieman, JA; Nugent, RA; Oien, NL; Schultz, BL; Stephanski, KJ; Wathen, MW; Wieber, JL; Zerth, HM | 1 |
Kemp, SD; Larder, BA; Lowe, DM; Parmar, V | 1 |
Quan, K; Tao, P; Zhang, X | 1 |
Kurth, R; Löwer, J; Oberg, B; Vrang, L | 1 |
Cheng, YC; Gonzalez, CJ; Im, GJ; Tramontano, E | 1 |
Blackburn, EH; Strahl, C | 1 |
Boretto, J; Canard, B; Capony, JP; Lazaro, JB; Selmi, B | 1 |
Feuston, B; Getty, K; Hazuda, DJ; Krueger, J; Lewis, D; Miller, MD; Munshi, V; Parniak, MA; Shaw-Reid, CA | 1 |
Ansó, E; Cruchaga, C; Martínez-Irujo, JJ; Rouzaut, A | 1 |
15 other study(ies) available for zidovudine triphosphate and foscarnet
Article | Year |
---|---|
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Point Mutation; Pyridines; Pyridones; Structure-Activity Relationship; Thiophenes; Viral Plaque Assay; Viral Proteins | 2005 |
HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Benzoxazoles; Cyclopropanes; DNA; Dose-Response Relationship, Drug; Drug Resistance, Viral; Enzyme Inhibitors; HIV Reverse Transcriptase; In Vitro Techniques; Inhibitory Concentration 50; Ligands; Models, Genetic; Oxazines; Pyridones; Reverse Transcriptase Inhibitors; Stochastic Processes; Transcription, Genetic; Virus Replication | 2007 |
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Topics: Antiviral Agents; Binding, Competitive; Cytomegalovirus; DNA-Directed DNA Polymerase; Enzyme Inhibitors; Ethylamines; Exodeoxyribonucleases; Herpes Zoster; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 4, Human; Humans; Models, Chemical; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship; Viral Proteins | 2007 |
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase.
Topics: Cytomegalovirus; Enzyme Inhibitors; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship | 2007 |
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cytomegalovirus; Drug Design; Enzyme Inhibitors; Esters; Furans; Herpesviridae; Herpesvirus 3, Human; Herpesvirus 4, Human; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleic Acid Synthesis Inhibitors; Pyridones; Simplexvirus | 2008 |
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
Topics: Antiviral Agents; Drug Design; Protease Inhibitors; Quinoxalines; Serine Endopeptidases | 2010 |
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Pyrroles; Quinolines; Solubility; Structure-Activity Relationship | 2010 |
Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.
Topics: Amino Acid Sequence; Dideoxynucleotides; DNA Mutational Analysis; Foscarnet; HIV-1; In Vitro Techniques; Kinetics; Molecular Sequence Data; Phosphonoacetic Acid; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thymine Nucleotides; Zidovudine | 1991 |
The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA.
Topics: Antiviral Agents; Dideoxynucleotides; Foscarnet; HIV; Infectious Anemia Virus, Equine; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1990 |
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
Topics: Animals; Dideoxynucleotides; Foscarnet; HIV-1; HIV-2; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Thymine Nucleotides; Zidovudine | 1988 |
Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
Topics: Amino Acids; Antiviral Agents; Binding Sites; Dideoxynucleotides; Diphosphates; Drug Resistance, Microbial; Foscarnet; HIV Reverse Transcriptase; HIV-1; Kinetics; Recombinant Proteins; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1993 |
Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
Topics: Antiviral Agents; Arabinonucleosides; Cell Division; Cell Line; Dideoxynucleosides; Dideoxynucleotides; DNA; Drug Interactions; Foscarnet; Humans; Oligonucleotide Probes; Repetitive Sequences, Nucleic Acid; Reverse Transcriptase Inhibitors; Telomerase; Telomere; Thymine Nucleotides; Zidovudine | 1996 |
Phosphorylation of AZT-resistant human immunodeficiency virus type 1 reverse transcriptase by casein kinase II in vitro: effects on inhibitor sensitivity.
Topics: Amino Acid Motifs; Amino Acid Sequence; Binding Sites; Casein Kinase II; Consensus Sequence; Dideoxynucleotides; DNA; DNA Repair; Drug Resistance, Microbial; Enzyme Activation; Foscarnet; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Peptide Mapping; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphoserine; Phosphothreonine; Protein Serine-Threonine Kinases; Recombinant Proteins; Reverse Transcriptase Inhibitors; Substrate Specificity; Thymine Nucleotides; Zidovudine | 2000 |
Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Topics: Anti-HIV Agents; Binding Sites; Butyrates; Catalysis; Dideoxynucleotides; DNA-Directed DNA Polymerase; Drug Combinations; Drug Synergism; Foscarnet; HIV Reverse Transcriptase; Hydrolysis; Kinetics; Nucleic Acid Synthesis Inhibitors; Oxazines; Reverse Transcriptase Inhibitors; Ribonuclease H; Thiophenes; Thymine Nucleotides; Zidovudine | 2005 |
Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate.
Topics: Antiviral Agents; Binding Sites; Catalysis; Dideoxynucleotides; Foscarnet; HIV Reverse Transcriptase; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Zidovudine | 2006 |